PBYI Company Profile and Key Details

Q: Who are the executives of PBYI?

Mr. Douglas Hunt B.Sc., FRAPSSenior Vice President of Regulatory Affairs, Pharmacovigilance, Medical Affairs & LawMr. Alan H. AuerbachFounder, Chairman, Pres, Chief Executive Officer & Sec.Mr. Maximo F. NouguesChief Financial Officer & Principal Accounting OfficerDr. Alvin F. Wong Pharm.d.Chief Scientific OfficerMr. Jeffrey Jerome LudwigChief Commercial OfficerMr. Mariann OhanesianSenior Director of Investor Relations

NASDAQ : PBYI

Puma Biotechnology

$9.17

0.12+1.33%

At Close 4:00 PM

67.57

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Puma Biotechnology, Inc. (PBYI) stock surged +1.33%, trading at $9.17 on NASDAQ, up from the previous close of $9.05. The stock opened at $8.90, fluctuating between $8.90 and $9.22 in the recent session.

Stock Snapshot

9.05

Prev. Close

466.75M

Market Cap

8.9

Day Low

15.03

P/E Ratio

0.61

EPS (TTM)

0.3

Cash Flow per Share

8.9

Open

50.9M

Number of Shares

9.22

Day High

76.56%

Free Float in %

1.12

Book Value

173.43K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	9.01	9.22	8.90	9.17	173.43K
Sep 09, 2026	9.31	9.45	9.01	9.05	453.58K
Sep 08, 2026	9.25	9.57	8.85	9.39	365.4K
Sep 04, 2026	9.40	9.64	9.31	9.55	185.91K
Sep 03, 2026	9.72	9.72	9.37	9.41	244.26K
Sep 02, 2026	9.40	9.74	9.28	9.69	410.69K
Sep 01, 2026	9.11	9.59	9.11	9.35	457.97K
Aug 31, 2026	9.02	9.20	8.78	9.11	242.88K
Aug 28, 2026	9.24	9.26	9.02	9.06	235.03K
Aug 27, 2026	9.01	9.30	8.95	9.24	202.72K
Aug 26, 2026	9.31	9.31	9.04	9.16	374.46K
Aug 25, 2026	9.22	9.38	9.17	9.32	302.38K
Aug 24, 2026	9.30	9.30	8.99	9.12	266.14K
Aug 21, 2026	9.20	9.48	9.07	9.24	333.58K
Aug 20, 2026	9.45	9.45	9.03	9.11	389.25K
Aug 19, 2026	9.33	9.51	9.25	9.49	262.77K
Aug 18, 2026	8.80	9.34	8.80	9.24	244.69K
Aug 17, 2026	8.80	8.99	8.62	8.82	191.9K
Aug 14, 2026	8.84	8.89	8.53	8.83	232.93K
Aug 13, 2026	8.93	8.97	8.65	8.71	262.98K

Contact Details

Los Angeles, CA 90024

United States

https://www.pumabiotechnology.com 424 248 6500

About Company

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic HER2-positive breast cancer when used in combination with capecitabine. Furthermore, PB272 is being explored for solid tumors exhibiting HER2 mutations. The company holds a licensing agreement with Pfizer, Inc. for this drug and has established sub-licensing partnerships with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Established in 2010, Puma Biotechnology maintains its headquarters in Los Angeles, California.

Stock Peers

ARGX

-18.27-1.82%

argenx SE$984.04 REGN

-14.39-1.78%

Regeneron Pharmaceuticals, Inc.$793.26 MDGL

-13.54-2.48%

Madrigal Pharmaceuticals, Inc.$533.12 VRTX

-6.56-1.26%

Vertex Pharmaceuticals Incorporated$514.56 UTHR

-2.96-0.58%

United Therapeutics Corporation$503.86 KRYS

-2.54-0.73%

Krystal Biotech, Inc.$345.55 ONC

-9.2-2.62%

BeOne Medicines AG$341.80 PRAX

-6.73-1.95%

Praxis Precision Medicines, Inc.$338.57 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

1.2+0.42%

Ligand Pharmaceuticals Incorporated$289.25

Frequently Asked Questions

What is the current Puma Biotechnology, Inc. (PBYI) stock price?

Puma Biotechnology, Inc. (NASDAQ: PBYI) stock price is $9.17 in the last trading session. During the trading session, PBYI stock reached the peak price of $9.22 while $8.90 was the lowest point it dropped to. The percentage change in PBYI stock occurred in the recent session was 1.33% while the dollar amount for the price change in PBYI stock was $0.12.

PBYI's industry and sector of operation?

The NASDAQ listed PBYI is part of Biotechnology industry that operates in the broader Healthcare sector. Puma Biotechnology, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PBYI?

Mr. Douglas Hunt B.Sc., FRAPS
Senior Vice President of Regulatory Affairs, Pharmacovigilance, Medical Affairs & Law
Mr. Alan H. Auerbach
Founder, Chairman, Pres, Chief Executive Officer & Sec.
Mr. Maximo F. Nougues
Chief Financial Officer & Principal Accounting Officer
Dr. Alvin F. Wong Pharm.d.
Chief Scientific Officer
Mr. Jeffrey Jerome Ludwig
Chief Commercial Officer
Mr. Mariann Ohanesian
Senior Director of Investor Relations

How PBYI did perform over past 52-week?

PBYI's closing price is 113.26% higher than its 52-week low of $4.30 where as its distance from 52-week high of $9.74 is -5.85%.

How many employees does PBYI have?

Number of PBYI employees currently stands at 179.

Link for PBYI official website?

Official Website of PBYI is: https://www.pumabiotechnology.com

How do I contact PBYI?

PBYI could be contacted at phone 424 248 6500 and can also be accessed through its website. PBYI operates from 10880 Wilshire Boulevard, Los Angeles, CA 90024, United States.

How many shares of PBYI are traded daily?

PBYI stock volume for the day was 173.43K shares. The average number of PBYI shares traded daily for last 3 months was 340.12K.

What is the market cap of PBYI currently?

The market value of PBYI currently stands at $466.75M with its latest stock price at $9.17 and 50.9M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	179
Beta	1.22
Sales or Revenue	$235.64M
5Y Sales Change%	-0.244%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	179
Beta	1.22
Sales or Revenue	$235.64M
5Y Sales Change%	-0.244%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

PBYI Company Profile and Key Details

Puma Biotechnology

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Technical Performance

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Price Forecast & Outlook

Key Takeaways

Valuation Metrics